| 1 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
TNFRSF14 |
| 2 |
34382383 |
10.3324/haematol.2020.263251 |
2022 |
Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma. |
TNFRSF14 |
| 3 |
35038193 |
10.1111/his.14617 |
2022 |
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. |
TNFRSF14 |
| 4 |
35106936 |
10.1002/cam4.4550 |
2022 |
SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups. |
TNFRSF14 |
| 5 |
35609565 |
10.1182/bloodadvances.2022007322 |
2022 |
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile. |
TNFRSF14 |
| 6 |
35734168 |
10.3389/fimmu.2022.922471 |
2022 |
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment. |
TNFRSF14 |
| 7 |
35834399 |
10.1097/PAS.0000000000001932 |
2022 |
Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features. |
TNFRSF14 |
| 8 |
32855278 |
10.3324/haematol.2020.254854 |
2021 |
Genetic evolution of <i>in situ</i> follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype. |
TNFRSF14 |
| 9 |
33311649 |
10.1038/s41379-020-00720-7 |
2021 |
Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice. |
TNFRSF14 |
| 10 |
33395752 |
10.1016/j.tranon.2020.100977 |
2021 |
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation. |
TNFRSF14 |
| 11 |
33560380 |
10.1182/bloodadvances.2020002469 |
2021 |
Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features. |
TNFRSF14 |
| 12 |
33562694 |
10.3390/cancers13040641 |
2021 |
Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention. |
TNFRSF14 |
| 13 |
33945543 |
10.1371/journal.pone.0248886 |
2021 |
Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes. |
TNFRSF14 |
| 14 |
33959502 |
10.3389/fonc.2021.638897 |
2021 |
c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study. |
TNFRSF14 |
| 15 |
33964277 |
10.1016/j.humpath.2021.04.014 |
2021 |
Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma. |
TNFRSF14 |
| 16 |
33968070 |
10.3389/fimmu.2021.666935 |
2021 |
Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells. |
TNFRSF14 |
| 17 |
34021249 |
10.1038/s41375-021-01289-z |
2021 |
Thyroid MALT lymphoma: self-harm to gain potential T-cell help. |
TNFRSF14 |
| 18 |
34069564 |
10.3390/ijms22105352 |
2021 |
The Tumor Microenvironment in Follicular Lymphoma: Its Pro-Malignancy Role with Therapeutic Potential. |
TNFRSF14 |
| 19 |
34374220 |
10.1002/cjp2.223 |
2021 |
c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma. |
TNFRSF14 |
| 20 |
34478526 |
10.1182/bloodadvances.2021005215 |
2021 |
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype. |
TNFRSF14 |
| 21 |
34558064 |
10.1111/bjh.17824 |
2021 |
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases. |
TNFRSF14 |
| 22 |
34671837 |
10.1007/s00292-021-01011-x |
2021 |
[Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma]. |
TNFRSF14 |
| 23 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
TNFRSF14 |
| 24 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
TNFRSF14 |
| 25 |
32239385 |
10.1007/s11523-020-00710-4 |
2020 |
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. |
TNFRSF14 |
| 26 |
32304999 |
10.1016/j.ebiom.2020.102731 |
2020 |
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab. |
TNFRSF14 |
| 27 |
33045225 |
10.1016/j.humpath.2020.09.014 |
2020 |
The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. |
TNFRSF14 |
| 28 |
33188997 |
10.1016/j.ctarc.2020.100235 |
2020 |
Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study. |
TNFRSF14 |
| 29 |
33211828 |
10.1182/bloodadvances.2020002944 |
2020 |
Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. |
TNFRSF14 |
| 30 |
30696620 |
10.1182/blood-2018-08-871293 |
2019 |
Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma. |
TNFRSF14 |
| 31 |
30819919 |
10.3324/haematol.2018.211631 |
2019 |
A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma. |
TNFRSF14 |
| 32 |
30885361 |
10.1016/bs.acr.2019.01.004 |
2019 |
HVEM network signaling in cancer. |
TNFRSF14 |
| 33 |
30918139 |
10.3960/jslrt.19003 |
2019 |
High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation. |
TNFRSF14 |
| 34 |
31368914 |
10.1097/PAS.0000000000001338 |
2019 |
Indolent In Situ B-Cell Neoplasms With MYC Rearrangements Show Somatic Mutations in MYC and TNFRSF14 by Next-generation Sequencing. |
TNFRSF14 |
| 35 |
29674500 |
10.3324/haematol.2018.191601 |
2018 |
Novel <i>GPR34</i> and <i>CCR6</i> mutation and distinct genetic profiles in MALT lymphomas of different sites. |
TNFRSF14 |
| 36 |
29738359 |
10.1097/PAS.0000000000001071 |
2018 |
Genomic Profile and Pathologic Features of Diffuse Large B-Cell Lymphoma Subtype of Methotrexate-associated Lymphoproliferative Disorder in Rheumatoid Arthritis Patients. |
TNFRSF14 |
| 37 |
29858685 |
10.1007/s00428-018-2384-3 |
2018 |
Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein. |
TNFRSF14 |
| 38 |
30126979 |
10.1182/blood-2018-03-837252 |
2018 |
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles. |
TNFRSF14 |
| 39 |
27297871 |
10.1111/his.13015 |
2017 |
Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications. |
TNFRSF14 |
| 40 |
28533310 |
10.1182/blood-2017-03-776278 |
2017 |
Mutations of <i>MAP2K1</i> are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. |
TNFRSF14 |
| 41 |
26650888 |
10.1002/gcc.22331 |
2016 |
Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma. |
TNFRSF14 |
| 42 |
26965583 |
10.1038/modpathol.2016.51 |
2016 |
Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. |
TNFRSF14 |
| 43 |
27086936 |
10.3109/10428194.2016.1165816 |
2016 |
Rubinstein-Taybi syndrome - a window into follicular lymphoma biology. |
TNFRSF14 |
| 44 |
27098631 |
|
2016 |
Extranodal B Cell Lymphoma with Prominent Spindle Cell Features Arising in Uterus and in Maxillary Sinus: Report of Two Cases and Literature Review. |
TNFRSF14 |
| 45 |
27103745 |
10.1182/blood-2015-10-679191 |
2016 |
TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses. |
TNFRSF14 |
| 46 |
27257180 |
10.1182/blood-2016-03-703819 |
2016 |
Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene. |
TNFRSF14 |
| 47 |
27325104 |
10.1182/blood-2015-12-682591 |
2016 |
Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations. |
TNFRSF14 |
| 48 |
27693350 |
10.1016/j.cell.2016.08.032 |
2016 |
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells. |
TNFRSF14 |
| 49 |
27750045 |
10.1016/j.ajpath.2016.07.027 |
2016 |
B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains. |
TNFRSF14 |
| 50 |
26366710 |
10.1038/nm.3943 |
2015 |
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. |
TNFRSF14 |
| 51 |
24162788 |
10.3324/haematol.2013.094474 |
2014 |
Early lesions of follicular lymphoma: a genetic perspective. |
TNFRSF14 |
| 52 |
24435047 |
10.1182/blood-2013-05-500264 |
2014 |
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. |
TNFRSF14 |
| 53 |
24942943 |
10.3960/jslrt.54.23 |
2014 |
Molecular pathogenesis of follicular lymphoma. |
TNFRSF14 |
| 54 |
25277889 |
10.1016/j.bbrc.2014.09.084 |
2014 |
CD160 expression defines a uniquely exhausted subset of T lymphocytes in HTLV-1 infection. |
TNFRSF14 |
| 55 |
23297126 |
10.1182/blood-2012-09-457283 |
2013 |
Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. |
TNFRSF14 |
| 56 |
23306973 |
10.2340/00015555-1523 |
2013 |
Serum-soluble herpes virus entry mediator levels reflect disease severity and Th2 environment in cutaneous T-cell lymphoma. |
TNFRSF14 |
| 57 |
23445872 |
10.3324/haematol.2012.073916 |
2013 |
Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas. |
TNFRSF14 |
| 58 |
24052547 |
10.1182/blood-2013-04-496893 |
2013 |
EZH2 mutations are frequent and represent an early event in follicular lymphoma. |
TNFRSF14 |
| 59 |
21941365 |
10.1038/leu.2011.266 |
2012 |
High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis. |
TNFRSF14 |
| 60 |
22297640 |
10.1038/jid.2011.470 |
2012 |
Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma. |
TNFRSF14 |
| 61 |
22343534 |
10.1073/pnas.1121343109 |
2012 |
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. |
TNFRSF14 |
| 62 |
22634623 |
10.4049/jimmunol.1102807 |
2012 |
B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation. |
TNFRSF14 |
| 63 |
23023713 |
10.1172/JCI63186 |
2012 |
Pathogenesis of follicular lymphoma. |
TNFRSF14 |
| 64 |
20946916 |
10.1016/j.imlet.2010.10.007 |
2011 |
Immunohistochemical analysis of HLDA9 Workshop antibodies against cell-surface molecules in reactive and neoplastic lymphoid tissues. |
TNFRSF14 |
| 65 |
20884631 |
10.1158/0008-5472.CAN-10-2460 |
2010 |
Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. |
TNFRSF14 |
| 66 |
19573080 |
10.1111/j.1365-2141.2009.07790.x |
2009 |
Common genetic variants in candidate genes and risk of familial lymphoid malignancies. |
TNFRSF14 |
| 67 |
19762537 |
10.1309/AJCPPHKGYYGGL39C |
2009 |
High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. |
TNFRSF14 |
| 68 |
19773279 |
10.1136/oem.2008.044024 |
2009 |
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. |
TNFRSF14 |
| 69 |
14562115 |
10.1038/sj.leu.2403175 |
2003 |
Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity. |
TNFRSF14 |
Datasets
Models
